within Pharmacolibrary.Drugs.ATC.G;

model G03AA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.84,
    Cl             = 0.16666666666666666,
    adminDuration  = 600,
    adminMass      = 0.00015,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.025,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Desogestrel and ethinylestradiol is a combined oral contraceptive containing a progestogen (desogestrel) and an estrogen (ethinylestradiol), used for the prevention of pregnancy. It is widely approved and utilized globally as a contraceptive option.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from studies in healthy adult women using combined desogestrel 150 μg and ethinylestradiol 30 μg oral contraceptives.</p><h4>References</h4><ol><li>F Z Stanczyk,Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.,Contraception,1997<a href='https://pubmed.ncbi.nlm.nih.gov/9220223/'>https://pubmed.ncbi.nlm.nih.gov/9220223/</a></li><li>H D McClamrock, E Y Adashi,Pharmacokinetics of desogestrel.,American journal of obstetrics and gynecology,1993<a href='https://pubmed.ncbi.nlm.nih.gov/8447355/'>https://pubmed.ncbi.nlm.nih.gov/8447355/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03AA09;
